KORU Medical Systems (KRMD)
Builds mechanical infusion systems for at-home subcutaneous biologic delivery.
KORU Medical Systems, Inc. (KRMD) Q2 2026 Earnings Call Transcript
KORU Medical Systems, Inc. (KRMD) Q2 2026 Earnings Call Transcript
KORU Medical Systems, Inc. (KRMD) Q2 Earnings and Revenues Beat Estimates
KORU Medical Systems, Inc. (KRMD) came out with quarterly earnings of $0.01 per share, beating the Zacks Consensus Estimate of a loss of $0.02 per share. This compares to break-even earnings per share a year ago.
Kaskela Law LLC Announces Investigation of KORU Medical Systems, Inc. (KRMD) and Encourages Long-Term KRMD Shareholders to Contact the Firm
PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law is investigating KORU Medical Systems, Inc. (Nasdaq: KRMD) (“KORU”) on behalf of the company's current shareholders.The investigation seeks to determine whether KORU and/or the company's officers and directors violated the securities laws or breached their fiduciary duties in connection with recent corporate actions.KORU shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) for additional information abo.
KORU Medical Systems, Inc. (KRMD) Q1 2026 Earnings Call Transcript
KORU Medical Systems, Inc. (KRMD) Q1 2026 Earnings Call Transcript
KORU Medical Systems, Inc. (KRMD) Reports Q1 Loss, Tops Revenue Estimates
KORU Medical Systems, Inc. (KRMD) came out with a quarterly loss of $0.02 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.03 per share a year ago.
KORU Medical Systems, Inc. $KRMD Shares Bought by Acuitas Investments LLC
Acuitas Investments LLC grew its holdings in KORU Medical Systems, Inc. (NASDAQ: KRMD) by 89.6% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 763,088 shares of the company's stock after acquiring an additional 360,594 shares during the period. Acuitas
KORU Medical Systems, Inc. (KRMD) Q4 2025 Earnings Call Transcript
KORU Medical Systems, Inc. (KRMD) Q4 2025 Earnings Call Transcript
KORU Medical Systems, Inc. (KRMD) Reports Q4 Loss, Beats Revenue Estimates
KORU Medical Systems, Inc. (KRMD) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to a loss of $0.03 per share a year ago.
Brokerages Set KORU Medical Systems, Inc. (NASDAQ:KRMD) Price Target at $6.13
KORU Medical Systems, Inc. (NASDAQ: KRMD - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the six brokerages that are presently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, one has given a hold recommendation, three have assigned a buy recommendation and
Down 18.1% in 4 Weeks, Here's Why KORU Medical Systems, Inc. (KRMD) Looks Ripe for a Turnaround
The heavy selling pressure might have exhausted for KORU Medical Systems, Inc. (KRMD) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Analyzing KORU Medical Systems (NASDAQ:KRMD) and Outset Medical (NASDAQ:OM)
Outset Medical (NASDAQ: OM - Get Free Report) and KORU Medical Systems (NASDAQ: KRMD - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, profitability, dividends, risk and earnings. Analyst Recommendations This is a breakdown
KORU Medical Systems, Inc. (NASDAQ:KRMD) Receives $6.13 Average PT from Analysts
KORU Medical Systems, Inc. (NASDAQ: KRMD - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the six ratings firms that are presently covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, one has given a hold recommendation, three have issued a buy recommendation and one
KORU Medical Systems, Inc. (KRMD) Soars 5.6%: Is Further Upside Left in the Stock?
KORU Medical Systems, Inc. (KRMD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Acuitas Investments LLC Reduces Position in KORU Medical Systems, Inc. $KRMD
Acuitas Investments LLC lessened its stake in KORU Medical Systems, Inc. (NASDAQ: KRMD) by 53.9% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 185,353 shares of the company's stock after selling 217,141 shares during the period. Acuitas Investments LLC
All You Need to Know About KORU Medical Systems, Inc. (KRMD) Rating Upgrade to Buy
KORU Medical Systems, Inc. (KRMD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
KRMD Submits 510(k) to Use FreedomEDGE System With Oncology Biologic
KORU Medical filed a 510(k) to use FreedomEDGE for subcutaneous PHESGO delivery, expanding into oncology and simplifying breast cancer care.
Albion Financial Group UT Sells 140,000 Shares of KORU Medical Systems, Inc. $KRMD
Albion Financial Group UT trimmed its position in shares of KORU Medical Systems, Inc. (NASDAQ: KRMD) by 39.3% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 216,374 shares of the company's stock after selling 140,000 shares during the period. Albion Financial
KORU Medical Systems (NASDAQ:KRMD) & P3 Health Partners (NASDAQ:PIII) Head to Head Survey
P3 Health Partners (NASDAQ: PIII - Get Free Report) and KORU Medical Systems (NASDAQ: KRMD - Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, risk, earnings, institutional ownership, analyst recommendations and valuation. Risk and Volatility P3 Health
Head to Head Review: KORU Medical Systems (NASDAQ:KRMD) and Veeva Systems (NYSE:VEEV)
Veeva Systems (NYSE: VEEV - Get Free Report) and KORU Medical Systems (NASDAQ: KRMD - Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, valuation, earnings, analyst recommendations, institutional ownership, profitability and risk. Analyst Recommendations This is a breakdown of
KORU Medical Systems, Inc. (KRMD) Q3 2025 Earnings Call Transcript
KORU Medical Systems, Inc. ( KRMD ) Q3 2025 Earnings Call November 12, 2025 4:30 PM EST Company Participants Linda Tharby - President, CEO & Director Tom Adams - CFO, Secretary & Treasurer Conference Call Participants Louisa Smith - Gilmartin Group LLC Frank Takkinen - Lake Street Capital Markets, LLC, Research Division Caitlin Cronin - Canaccord Genuity Corp., Research Division Joseph Downing - Piper Sandler & Co., Research Division Chase Knickerbocker - Craig-Hallum Capital Group LLC, Research Division Presentation Operator Greetings, and welcome to KORU Medical Systems Third Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note, this conference is being recorded.